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Background: It is increasingly evident that perturbations to the diversity and composition of the gut microbiota
have significant consequences for the regulation of integrative physiological systems. There is growing interest
in the potential contribution ofmicrobiota-gut-brain signalling to cardiorespiratory control in health and disease.
Methods: In adult male rats, we sought to determine the cardiorespiratory effects of manipulation of the gut mi-
crobiota following a 4-week administration of a cocktail of antibiotics. We subsequently explored the effects of
administration of faecal microbiota from pooled control (vehicle) rat faeces, given by gavage to vehicle- and an-
tibiotic-treated rats.
Findings: Antibiotic intervention depressed the ventilatory response to hypercapnic stress in conscious animals,
owing to a reduction in the respiratory frequency response to carbon dioxide. Baseline frequency, respiratory
timing variability, and the expression of apnoeas and sighswere normal. Microbiota-depleted rats had decreased
systolic blood pressure. Faecal microbiota transfer to vehicle- and antibiotic-treated animals also disrupted the
gut microbiota composition, associatedwith depressed ventilatory responsiveness to hypercapnia. Chronic anti-
biotic intervention or faecal microbiota transfer both caused significant disruptions to brainstem monoamine
neurochemistry, with increased homovanillic acid:dopamine ratio indicative of increased dopamine turnover,
which correlated with the abundance of several bacteria of six different phyla.
Interpretation: Chronic antibiotic administration and faecalmicrobiota transfer disrupt gutmicrobiota, brainstem
monoamine concentrations and the ventilatory response to hypercapnia. We suggest that aberrant microbiota-
gut-brain axis signalling has a modulatory influence on respiratory behaviour during hypercapnic stress.
Funding: Department of Physiology and APC Microbiome Ireland, University College Cork, Ireland.
© 2019 Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).
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1. Introduction
There is a growing understanding of the significance of the gastroin-
testinal microbiome and its modulatory capacity in the homeostatic
regulation ofmultiple physiological systems [1]. Trillions of gutmicrobi-
ota form a co-dependent, mutualistic relationship with the host, con-
tributing to whole-body health [2], through an extensive multimodal
communication pathway termed the ‘microbiota-gut-brain axis’ [3].
Dysregulated microbiota-gut-brain axis signalling disrupts major
neurocontrol systems affecting anxiety, pain, depression and social be-
haviours [4–10]. Multiple contributors to microbiota-gut-brain axis
communication have been identified, including neural pathways, im-
mune mediators, bacterial metabolites, serotonin and tryptophan me-
tabolism, host genetics and gut hormones [11]. There is a wide
appreciation of the potential contribution of microbiota-gut-brain sig-
nalling to cardiorespiratory control in health and disease [12–17].
The cardiorespiratory system is tightly regulated by neuronal net-
works residing within the brainstem. Respiratory rhythm and pattern,
generated by complex brainstem networks is transduced via multiple
efferent pathways, directly or indirectly via the spinal nuclei to the stri-
ated muscles of breathing, which provides for exquisite breath-by-
breath control of pulmonary ventilation [18,19]. Autonomic centres
within the medulla oblongata (dorsal motor nucleus of the vagus, nu-
cleus ambiguus and rostral ventrolateral medulla) transduce parasym-
pathetic and sympathetic motor outflow to the heart and circulation.
Of interest, there is considerable respiratory-related modulation of au-
tonomic efferent signalling. The vagus nerve, a key bi-directional com-
munication pathway of the microbiota-gut-brain axis [20], provides
visceral information from sensors in multiple peripheral sites to the nu-
cleus of the solitary tract within the brainstem. There is considerable
sensory-cued modulation of respiratory motor and autonomic outputs,
from the periphery, which execute efficient cardiorespiratory control.
Notwithstanding the primary homeostatic function of the neural net-
works governing breathing and blood pressure regulation, there is
ample evidence in support of a remarkable capacity for plasticity at
multiple sites within the control network, both at a central and periph-
eral level, which underpin adaptive andmaladaptive outcomes [21–25].
Maladaptive plasticity expressed in several stress models have re-
vealed considerable long-lasting perturbations to respiratory control,
with deleterious consequences for whole-body health [26–30]. Prenatal
stress results in enhanced respiratory variability and alters ventilatory
control during hypoxic and hypercapnic chemostimulation in rat off-
spring during adulthood [15]. Interestingly, respiratory frequency re-
sponses to hypercapnia correlated with alterations in the gut
microbiota [15]. Recently, exposure to chronic intermittent hypoxia,
modelling human sleep apnoea,was shown to disrupt cardiorespiratory
homeostasis, with evidence of decreased prevalence of protective sigh
behaviours, altered autonomic control of heart rate, decreased
brainstem noradrenaline concentration, and altered gut microbiota
composition [16]. To our knowledge, there are noother studies of the ef-
fects of manipulation of the microbiota on the control of breathing. Yet
importantly, animal models of sleep-disordered breathing show evi-
dence of alteredmicrobiota composition anddiversity, driven by altered
diet and/or exposure to intermittent hypoxia [12,31–33]. Thus, it ap-
pears that respiratory dysregulation has the capacity to alter themicro-
biota. It is important to determine if disruption to themicrobiota affects
respiratory homeostasis.
Of relevance, the gutmicrobiota are importantmodulators of cardio-
vascular control. The transfer of faeces fromhypertensive donors (spon-
taneously hypertensive rats, a hypertensive model of sleep-disordered
breathing fed a high-fat diet, and hypertensive human donors) into nor-
motensive recipient or germ-free animals leads to the development of
hypertension in the recipient animal [12,14,34,35]. A decrease in buty-
rate-producing and an increase in lactate-producing bacteria are associ-
ated with a hypertensive phenotype [12,14,35]. More recently, it was
established in an animal model of obstructive sleep apnoea that acetate
is a key player in blood pressure regulation [17]. Collectively, thesefind-
ings suggest an influential role for the microbiota-gut brain axis in car-
diovascular homeostasis.
It is established that chronic administration of a cocktail of broad-
spectrum antibiotics significantly depletes the gut microbiota [36,37].
It is also recognised that alterations to the gut microbiota can influence
brain behaviours at a functional level [5,6,8,36]. Thus, we sought to per-
form a comprehensive assessment of cardiorespiratory physiology in
the context of amanipulated gutmicrobiota. We examined cardiorespi-
ratory control and reflex responsiveness in adult rats following a 4-
week antibiotic intervention period. We hypothesised that there
would be evidence of aberrant plasticity in cardiorespiratory control in
antibiotic-treated rats. Thereafter, in a subset of animals, we explored
ifmanipulation of themicrobiota via faecalmicrobiota transfer could re-
verse or ameliorate the putative deleterious effects of antibiotic inter-
vention on cardiorespiratory control.
2. Methods
2.1. Ethical approval
All procedures on live animals were performed under licence from
the Government of Ireland Department of Health (B100/4498) in accor-
dance with National and European Union directive 2010/63/EU, with
prior ethical approval byUniversity College Cork (AEEC#2013/035). Ex-
perimentswere conducted in accordancewith guidelines established by
University College Cork's Animal Welfare Body.
2.2. Experiment animals
Ten-week old adult male Sprague Dawley rats (n=40; purchased
from Envigo, UK) were housed as age-matched pairs in standard rat
cages. All animals were housed under a 12-h light: 12-h dark cycle
with standard rodent chow available ad libitum.
Research in context
Evidence before this study
The microbiota-gut-brain axis is implicated in the homeostatic
control of physiological systems; however, its potential influence
on the control of breathing is unclear.
Added value of this study
Chronic antibiotic administration in rats depleted gut microbiota,
increased gut permeability, altered brainstem neurochemistry
and depressed the ventilatory response to hypercapnic stress.
Faecal microbiota transfer in vehicle- and antibiotic-treated rats
significantly disrupted the microbiota composition, with associ-
ated disruptions to brainstem neurochemistry and depressed ven-
tilation during hypercapnia. Brainstem monoamine
neurochemistry correlated with the relative abundance of several
bacteria, primarily of the Firmicutes phylum.
Implications of all the available evidence
Manipulation of the gut microbiota disrupts respiratory behaviour
suggesting that the microbiota-gut-brain axis has the capacity to
alter respiratory control through aberrant neuromodulation of
breathing.
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2.3. Antibiotic administration
Rats were randomly allocated to receive autoclaved deionised water
(vehicle, VEH; n=20) or broad-spectrum antibiotics (ABX; n= 20) in
autoclaved deionised water for 4-weeks. To deplete the microbiota, we
used an antibiotic cocktail consisting of ampicillin (1 g/l), vancomycin
(500 mg/l), ciprofloxacin (20mg/l), imipenem(250mg/l) andmetroni-
dazole (1 g/l) [5,36]. Water bottles were replenished every second day
and water consumption recorded per cage. Animal body weights were
monitored daily (Supplementary Fig. 1a). Weight loss in the beginning
of ABX intervention is a commonly reported side effect related to the
aversive taste of the ABX cocktail. Fresh bedding was given to ABX and
VEH groups every other day to decrease the risk of microbiota re-estab-
lishment in ABX animals.
2.4. Faecal microbiota transfer (FMT) protocol
2.4.1. Collection and processing of donor microbiota for faecal microbiota
transplantation
Donor faecal microbiota was acquired from the pooled faeces of 10
VEH rats, collected fresh from individual animals by massaging the
lower abdomen and promoting the passage of faeces from the rats.
Both the collection and the transportation and processing of faeces oc-
curred under anaerobic conditions to prevent loss of anaerobicmicrobi-
ota. Sterile reduced phosphate-buffered saline (PBS; 10ml) containing
20% glycerol (v/v)was added to each 1 g of pooled faeces. The faecalma-
terial was thoroughly re-suspended. Samples were centrifuged at 2000
rpm for 5 min at 4 °C (MIKRO 22R refrigerated centrifuge) to generate a
sediment of undigested dietary fibres. Supernatantswere aliquoted, fro-
zen and stored at−80 °C until use in oral gavage.
2.4.2. Administration of FMT
ABX rats (n= 10) received a washout period of autoclaved
deionised water for three days and VEH rats (n = 10) remained on
autoclaved deionised water. Two inoculations of donor microbiota
(300 μl) were administered via oral gavage to ABX and VEH rats, on
day 1 and day 7 following the washout period. To reinforce the donor
microbiota phenotype, the ABX rats were transferred to bedding previ-
ously occupied by VEH rats on inoculation day 1 and thereafter on a
weekly basis (ABX-FMT group). VEH rats were transferred to fresh
bedding adhering to the pattern described above (VEH-FMT group).
All animals received autoclaved deionised water for the duration of
the 4-week period (Fig. 1).
2.5. Assessment of respiratory flow and metabolism in unrestrained,
unanaesthetised rats
2.5.1. Whole-body plethysmography
Whole-body plethysmography (DSI, St. Paul, Minnesota, USA) was
used to record respiratory flow during quiet rest in unrestrained,
unanaesthetised rats. This was performed at the animal housing facility
of University College Cork as this subset of animals subsequently
remained in the facility for faecal microbiota transfer and housing for
a further period of 4 weeks (Section 2.4.2). Animals were introduced
into custom chambers (601-1427-001 PN, DSI) with room air pumped
through the chambers (3 l/min) ensuring the maintenance of oxygen
(O2) and carbon dioxide (CO2). Animals were allowed to acclimate for
30–90 min to allow habituation to the surroundings. Contemporaneous
observationswere performed in ABX (n=10) versusVEH (n= 10) and
subsequently ABX-FMT (n= 10) versusVEH-FMT (n= 10) using a pair
of plethysmograph chambers.
2.5.2. Metabolic measurements
CO2 production (VCO2) and O2 consumption (VO2) were measured
in animals throughout the whole-body plethysmography protocol (O2
and CO2 analyser; AD Instruments, Colorado Springs, CO, USA) as previ-
ously described [38–41].
2.5.3. Experimental protocol
Once the acclimation period was complete, a 10–15-min steady-
state normoxia period allowed for the assessment of baseline parame-
ters (FiO2 = 0.21; balance N2). Thereafter, rats were exposed to a 10-
min poikilocapnic hypoxia challenge (FiO2 = 0.10; balance N2). Each
animal was then allowed to recover during normoxia (FiO2 = 0.21; bal-
ance N2) to re-establish stable breathing. Subsequently, another base-
line period was recorded and rats were then exposed to a hypercapnic
challenge (FiCO2= 0.05; balance O2) for 10min followed by a recovery
period. A new baseline period was determined and animals were then
exposed to 10 successive cycles of acute intermittent hypoxia (AIH),
consisting of alternating periods of normoxia (FiO2 = 0.21; balance
Faecal microbiota transplant
Whole-body plethysmography, cardiorespiratory recordings
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and tissue collection in 
VEH-FMT (n=10) and ABX-FMT (n=10)
1 week
Whole body plethysmography  
in VEH (n=10) and ABX (n=10)
           Cardiorespiratory recordings  under urethane anaesthesia
                              and tissue collection in VEH (n=10) 
                                              and ABX (n=10)Antibiotic administration (ABX)
 (n=10)
Antibiotic administration (ABX)
 (n=10)
Faecal microbiota transfer (ABX-FMT)
 (n=10)
Faecal microbiota transfer (VEH-FMT)
 (n=10)
Vehicle (VEH)
(n=10)
Vehicle (VEH)
 (n=10)
skeew4skeew4
3 day
washout
3 day
washout
3 days
Fig. 1. Experimental design. Schematic representation of the experimental design employed in the study.
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N2) for 6 min and hypoxia (FiO2= 0.10, balance N2) for 6 min. Follow-
ing the AIH protocol, a normoxia period was established (FiO2 = 0.21;
balance N2) for 1 h. On completion of the experimental protocol, faecal
pellets in the plethysmograph chambers were counted per unit time.
2.5.4. Data analysis for whole-body plethysmography and metabolism
Respiratory parameters including respiratory frequency (fR), tidal
volume (VT), minute ventilation (VE), inspiratory time (Ti) and expira-
tory time (Te) were recorded on a breath-by-breath basis for analysis
(Finepoint software Buxco Research Systems, Wilmington, NC, USA).
Artefacts in the signals due to movement and sniffing were excluded
from analysis. A steady-state baseline period was averaged during
normoxia to assess ventilatory and metabolic parameters at quiet rest.
For acute hypoxic and hypercapnic challenges, respiratory and meta-
bolic data were averaged for the last 5 min of these exposures to ensure
adequate time for gas mixing in the chambers and assessment of
steady-state ventilatory and metabolic responses. Data are expressed
as a change in the absolute values from baseline values. Furthermore,
to determine the peak hypoxic ventilatory response, respiratory fre-
quency was averaged every 10 s for the first 120 s of the acute hypoxic
gas challenge. Similarly, for the acute hypercapnic challenge, the respi-
ratory frequency response was averaged for each minute of the 10-
min challenge. For AIH challenges, respiratory data were compared be-
tween groups for the last hypoxia challenge and expressed as a percent-
age change from the preceding baseline normoxia exposure. Data from
the post-AIH normoxic period was collected at 5 min intervals. The last
5-min epoch of the 1-h period of normoxia following exposure to AIH
was compared with the normoxic baseline period preceding AIH and
expressed as percentage change from baseline as a measure of AIH-in-
duced respiratory plasticity. Comparisons were made between the ex-
perimental groups. Respiratory flow signals were also analysed to
quantify the occurrence of apnoeas (post-sigh apnoeas and spontane-
ous apnoeas) and augmented breaths (sighs) during normoxic baseline
and hypoxic and hypercapnic breathing as previously described [42]. An
apnoea was defined as two consecutive missed breaths and data are
expressed as apnoea index (number of apnoeas per hour). Sighs (aug-
mented breaths) were distinguished as breaths with double the ampli-
tude of the average VT. Poincaré plotswere constructed showing breath-
to-breath (BBn) versus the subsequent breath-to-breath interval (BBn
+ 1) allowing determination of short-term (SD1) and long-term
(SD2) respiratory timing variability during stable baseline as well as
hypoxia and hypercapnia breathing. VT, VE, VT/Ti, VO2 and VCO2 were
normalised per 100 g body mass.
2.6. Assessment of cardiorespiratory parameters under urethane
anaesthesia
2.6.1. Surgical protocol and cardiorespiratory measures
Cardiorespiratory parameters were assessed in rats under urethane
anaesthesia (1.5 g/kg i.p.; 20% w/v) following isoflurane induction (5%
by inhalation in room air). Depth of anaesthesia was assessed through-
out the surgical and experimental protocol by carefully monitoring re-
flex responses to tail/paw pinch and the corneal reflex. If required,
supplemental doses of anaesthetic were given. Rats were placed in the
supine position and core body temperature was maintained at 37 °C
using a homeothermic blanket system (Harvard Apparatus, Holliston,
MA, USA) and a rectal temperature probe.
A mid-cervical tracheotomy was performed. The right jugular vein
was then cannulated for intravenous (i.v.) infusion of supplemental an-
aesthetic and drugs. Next, the right carotid artery was cannulated and a
pressure catheter inserted into the left ventricle to record left ventricu-
lar contractility (dP/dt max); artefacts were observed in the pressure
signals in some animals and data acquired from these animals was ex-
cluded. The femoral artery was cannulated for the recording of arterial
blood pressure and the withdrawal of arterial blood samples for blood
gas, pH and electrolyte analysis (i-STAT; Abbott Laboratoies Ltd). All
rats were maintained with a bias flow of supplemental O2 to preserve
arterial oxygen saturation above 95% during basal conditions (SaO2;
Starr Life Sciences, PA, USA). A pneumotachometer and a CO2 analyser
(microCapStar End-Tidal CO2 analyser; CWE Inc., USA) were connected
to a tracheal cannula to determine tracheal flow and end-tidal CO2
(ETCO2), respectively. A concentric needle electrode (26G; Natus
Manufacturing Ltd., Ireland) was inserted into the costal diaphragm
for the continuous measurement of diaphragm electromyogram
(EMG) activity. Signals were amplified (x5,000), filtered (band pass;
500–5000 Hz) and integrated (50 ms time constant; Neurolog system,
Digitimer Ltd., UK). LabChart v7 (ADInstruments) was used to display
data in real-time.
2.6.2. Experimental protocol
An arterial blood gas samplewas attained following a 30-minute pe-
riod of stabilisation. Following the stabilisation period, baseline param-
eters were assessed for 10 min. An electronic gas mixer (GSM-3 Gas
Mixer; CWE Inc.) was used to manipulate the gas composition of the
bias flow to administer chemostimulation challenges to the rat. The
rats were exposed to a graded hypercapnic challenge: FiCO2 = 0.05
and 0.10 (supplemental O2; balance N2) consecutively for 5 min each.
Following a recovery period, animals were challenged with
poikilocapnic hypoxia (FiO2 = 0.10, balance N2) for 5 min, followed by
a 5 min hypoxic hypercapnic challenge (FiO2 = 0.10, FiCO2= 0.05, bal-
ance N2). After the chemostimulation challenges and a sufficient recov-
ery period, the serotonin type 3 (5-HT3) receptor agonist
phenylbiguanide was administered in incremental doses (PBG; 2, 4, 8,
16, 32 μg/kg; i.v.) to stimulate pulmonary vagal afferent C-fibres
[43,44]. Then animals underwent bilateral cervical vagotomy. After a
20-min recovery period, another blood gas sample was acquired and
post-vagotomy baseline parameters were determined. The
chemostimulation challenges described above were repeated under
vagotomised conditions. Finally, a single bolus of 32 μg/kg PBG was ad-
ministered to confirm that PBG-induced pulmonary chemoreflex re-
sponses were entirely dependent upon vagal nerve transmission.
Animals were euthanised by urethane overdose i.v. and whole
brains were immediately harvested and frozen in−80 °C isopentane
and stored at−80 °C until required. The caecumwas removed, weighed
and caecal contents were removed rapidly and snap frozen in liquid ni-
trogen. The distal ileum and proximal colon were removed. The heart
was removed and the right ventricle and left ventricle + septum were
separated and weighed. The lungs were removed and weighed and
then were allowed to air dry at 37 °C for at least 48 h and re-weighed.
2.6.3. Data analysis of cardiorespiratory parameters in anaesthetised rats
10 min of stable recording were averaged (baseline data) and are
presented as absolute values. For cardiorespiratory and EMG responses
during graded hypercapnia, hypoxia, hypoxic hypercapnia, vagotomy
and chemostimulation challenges post-vagotomy, for each reported pa-
rameter, the average of the last minute of recordings was determined
and data were compared with the 1-minute pre-challenge baseline. To
assess the dynamic response to PBG administration, datawere averaged
in 3-second bins and the maximal response for each concentration was
determined for each cardiorespiratory parameter reported. Cardiovas-
cular responses to PBGwere expressed as absolute change from thepre-
ceding baseline value. Maximum apnoea and post-apnoea tachypnoea
data fromPBG stimulationwere expressed as theduration of the apnoea
or tachypnoea period normalised to the average cycle duration
determined during the baseline period preceding PBG challenges
i.e. fold change. Cardiorespiratory responses to vagotomy and
chemostimulation before and after vagotomy were expressed as abso-
lute change from the preceding baseline. EMG responses to vagotomy
and chemostimulation before and after vagotomy were expressed as
percent change from the preceding baseline value.
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2.7. Macromolecular permeability in small and large intestine ex vivo
2.7.1. Epithelial permeability: Ussing chambers
In a subset of animals, distal ileum and proximal colon were re-
moved and examined ex vivo. Distal ileum (a 2.0 cm segment adjacent
to the caecum) andproximal colon (2.0 cmmost distal segment of prox-
imal colon)were gently flushed, cut open along themesenteric line and
mounted in Ussing chambers with an exposed tissue area of 0.12cm2.
Tissue was bathed with Krebs solution (in mM: 1.2 NaH2PO4; 117
NaCl; 4.8 KCl; 1.2 MgCl2; 25 NaHCO3; 11 CaCl2 and 10 glucose) at 37 °
C with continuous carbogen (95% O2, 5% CO2) supply. 4-kDa FITC-dex-
tran (4 kDa, FD4, Sigma, Ireland) was added to the mucosal (luminal)
chamber at a final concentration of 2.5 mg/ml. To assess FITC flux
through the epithelial barrier, samples (200 μl) were collected from
the serosal chamber at 0 (baseline), 60 and 120 min after the addition
of FITC. At each time-point, the volume removed was replenished
with Krebs buffer. To exclude the potential contribution of ileac Na+-
glucose co-transporter (Slc5a1) to paracellular permeability, glucose
in the mucosal chamber buffer was substituted with 10 mM mannitol
in ileac tissue samples [45].
2.7.2. Data analysis
FITC was measured on VICTOR-1 plate reader (PerkinElmer) at 485
nm excitation/535 nm emission wavelengths. FITC mucosal-to-serosal
flux was calculated as an increment in fluorescence intensity versus
baseline fluorescence over time and presented as ng/ml.
2.8. Brainstem monoamine concentrations
2.8.1. High-performance liquid chromatography (HPLC) coupled to electro-
chemical detection for the measurement of brainstem monoamine
concentrations
After euthanasia, whole brains were immediately removed from the
rats and snap frozen in isopentane cooled in liquid nitrogen. Whole
brains were transferred to −80 °C for long-term storage. The frozen
brainstem was dissected from the brain at −20 °C and subsequently
sonicated in 1 ml of chilled mobile phase spiked with 2 ng/20 μl of N-
methyl 5-HT (internal standard) (Bandelin Sonolus HD 2070). High-
performance liquid chromatography was performed as previously de-
scribed [16]. The monoamines noradrenaline (NA), dopamine (DA), se-
rotonin (5-HT), monoamine precursor L-3,4-dihydroxyphenylalanine
(L-DOPA) and metabolites 5-hydroxyindoleacetic acid (5-HIAA) and
homovanillic acid (HVA) were assessed. Eachmonoamine and metabo-
lite were identified by their respective characteristic retention times.
This was determined by standard injections, which were run at regular
intervals during the sample analysis.
2.8.2. Data analysis
Class-VP5 software processed chromographs that identified specific
monoamines. Analyte:internal standard peak response ratios were used
to calculate concentrations. Data are expressed as nanograms of neuro-
transmitter per gram of tissue weight (ng/g).
2.9. 16S rRNA sequence-basedmicrobiota composition and diversity analy-
sis in caecal content
2.9.1. Caecal microbiota DNA extraction and 16S rRNA gene sequencing
DNA extraction and 16S rRNA gene sequencing was performed as
previously described [16].
2.9.2. Bioinformatic sequence analysis
FLASH (fast length adjustment of short reads to improve genome as-
semblies) was used to assemble 300 base paired-end reads. Thereafter,
QIIME suite of tools (Quantitative Insights Into Microbial Ecology) ver-
sion 1.9.0 was used to further process paired-end reads. This processing
included quality filtering based on a quality score N 25 and removal of
mismatched barcodes and sequences below length thresholds.
Denoising, chimera detection and operational taxonomic units (OTUs)
clustering were performed using USEARCH v7 (64-bit) [46]. PyNAST
(a flexible tool for aligning sequence to a template alignment) was
used to align OTUs. BLAST against the SILVA SSURef database release
123 was used to assign taxonomy. Alpha diversity was generated in
QIIME [47].
2.10. Statistical analysis
For data sets with confirmed normal distribution, a one-way ANOVA
with Bonferroni post hoc where appropriate or parametric two-tailed
Student's unpaired t-tests with Welch's correction where appropriate
were used to test for statistically significant between-group differences.
When the assumption of normal distribution was violated, a non-para-
metric Kruskal-Wallis with Dunn's post hocwhere appropriate or non-
parametric Mann-Whitney U tests where appropriate were used.
Two-way ANOVA or repeated measures two-way ANOVA with
Bonferroni post hoc where appropriate were used for relevant data
sets. Microbiota data are expressed as median (IQR). All other data
sets are expressed as means ± SD or are displayed graphically as box
and whisker plots (median, IQR and minimum to maximum values).
Microbiota analysis was performed in SPSS and R software environ-
ment. The OTUs detected only in ≤ two animals in each group were ex-
cluded from the analysis. Bacterial genera that were significantly
different at least in one comparison were used to construct the Log2
fold change ratio heatmap. The 2D principal coordinates analysis
(PCoA) plot based on Bray-Curtis distance matrices was constructed
using R (version 3.4.4), R Studio (version 1.1.453), and the “vegan”
package (version 2.5.1) using the vegdist function and recommended
parameters. For the correlation analysis between the microbiota com-
position and a large array of parameters including cardiorespiratory,
neuromodulators and intestinal permeability, Hierarchical All-against-
All association-testing (HAllA) was used (version 0.8.7) with Spearman
correlation as correlation metric and medoid as clustering method.
Spearman correlation coefficients were determined for a subset of asso-
ciations and data are graphically illustrated showing individual data
points. GraphPad Prism Software v6 (GraphPad Software, San Diego,
CA, USA) was used for all other statistical analysis. Statistical signifi-
cance was set at p b .05. Benjamini-Hochberg (BH) adjustment proce-
dure was applied with the false discovery rate (FDR) set at 10% and
20% to correct for multiple testing in the relative abundance and corre-
lation analyses, respectively. Adobe Illustrator CS5 (v15) was used to
edit figs.
3. Results
3.1. Body and tissue weights
Compared with VEH controls, ABX rats tended to be underweight
(Supplementary Fig. 1a), coincident with significantly reduced fluid in-
take during the first week of the experimental protocol (p= .001, two-
way ANOVA with Bonferroni post hoc, Supplementary Fig. 1b). During
respiratory assessment in the plethysmograph chambers, manipulation
of the gut microbiota altered faecal output per hour (p= .04, Kruskal-
Wallis, Supplementary Fig. 1c). Microbiota manipulation also signifi-
cantly altered tissue weights (Table 1).
3.2. Baseline ventilation and metabolism in behaving rats during quiet rest
During baseline breathing, VT, fR, and VE and VCO2 were all equiva-
lent between groups (Table 2). However, manipulation of the gut mi-
crobiota had a significant effect on the ventilatory equivalent for
carbon dioxide (VE/VCO2) (p= .042, one-way ANOVA, Table 2). VE/
VCO2 was significantly reduced in VEH-FMT rats compared with VEH
rats (one-way ANOVA with Bonferroni post hoc, Table 2).
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3.3. Respiratory timing variability, apnoeas and sighs during normoxia in
behaving rats during quiet rest
Assessments of both short-term (SD1) and long-term (SD2) respira-
tory timing variability during normoxia were equivalent between
groups: Ti (Table 2), Te (p N .05, one-way ANOVA, Fig. 3e, f) and total
breath duration (Ttot, p N .05, Fig. 3g, h). There was no difference in ap-
noea index (Fig. 3l) or sigh frequency (Fig. 3n) during normoxia be-
tween groups (p N .05). The apnoea index combines spontaneous and
post-sigh apnoeas, both of which were equivalent in their respective
prevalences between groups (p N .05). Furthermore, the average dura-
tion of apnoeas was equivalent between groups (Fig. 3m).
3.4. Ventilatory and metabolic responsiveness to chemostimulation in be-
having rats during quiet rest
3.4.1. Ventilatory and metabolic responsiveness to hypoxia
No significant differences were observed between respective groups
in ventilatory and metabolic responsiveness to hypoxia determined
under steady-state conditions during the last 5 min of exposure (two-
way ANOVA, Fig. 2b, c, f, g, j, k, repeated measures two-way ANOVA;
Supplementary Fig. 2a, b, e, f, i, j; and Table 3). However, analysis during
the first 120 s of hypoxia, when the peak hypoxic ventilatory response
was observed, revealed that manipulation of the gut microbiota had a
significant effect on minute ventilation due to a decrease in the
respiratory frequency response in ABX rats compared with VEH rats
(VE, time, p= .0001; ABX, p= .045; time x ABX, p= .459, two-way
ANOVA; fR, time, p= .0001; ABX, p= .022; time x ABX, p= .486,
two-way ANOVA, Supplementary Fig. 3a) and in VEH-FMT rats com-
pared with VEH rats (VE, time, p= .0001; FMT, p= .001; time x FMT,
p= .0009, two-way ANOVA; fR, time, p= .0001; FMT, p= .002; time
x FMT, p= .039, two-way ANOVA, Supplementary Fig. 3c). Ventilatory
responses to the AIH protocol were equivalent between respective
groups (p N .05; Supplementary Fig. 4, Supplementary Table 1).
3.4.2. Ventilatory and metabolic responsiveness to hypercapnia
Oneof themajorfindings of this study is thatmanipulation of the gut
microbiota has a significant effect on the ventilatory response to hyper-
capnia (p= .02, Kruskal-Wallis, Table 5).VEwas significantly blunted in
ABX rats compared with VEH rats (p= .038, two-way ANOVA, Fig. 2h;
and p= .045; Kruskal-Wallis with Dunn's post hoc, Table 5), a conse-
quence of reduced fR response to CO2 challenge (p= .044, two-way
ANOVA, Fig. 2d; and p= .043, one-way ANOVA with Bonferroni post
hoc, Table 5). Further analysis of the fR response during each minute of
the hypercapnic exposure revealed a significant difference in the fR re-
sponse to CO2 challenge in ABX rats compared with VEH rats (time, p
b .0001; ABX, p= .047; time x ABX, p= .638, Supplementary Fig. 5a).
The hypoventilation was evident as a blunted VE/VCO2 response in
ABX rats compared with VEH rats, however this was not statistically
Table 1
Body and organ weights.
VEH
(n= 10)
ABX
(n = 9)
VEH-FMT
(n = 10)
ABX-FMT
(n = 10)
One-way
ANOVA
VEH
vs ABX
VEH-FMT
vs ABX-FMT
VEH vs
VEH-FMT
ABX vs
ABX-FMT
VEH vs
ABX-FMT
ABX vs
VEH-FMT
Body mass(g) 380 ± 23 369 ± 22 436 ± 27 420 ± 24 b0.0001 0.999 0.888 0.0001 0.0002 0.004 0.0001
RV
(mg/100 g)
58 ± 6 51 ± 3 55 ± 7 61 ± 6 0.009 0.133 0.196 0.999 0.008 0.999 0.999
LV
(mg/100 g)
219 ± 14 207 ± 10 206 ± 14 208 ± 9 0.053 – – – – – –
LV + RV
(mg/100 g)
277 ± 16 258 ± 10 260 ± 14 269 ± 11 0.011 0.018 0.982 0.043 0.483 0.967 0.999
Lung dry weight
(mg/100 g)
100 ± 12 90 ± 11 98 ± 9 85 ± 10 0.01 0.217 0.067 0.999 0.999 0.015 0.723
Lung wet
weight
(mg/100 g)
495 ± 104 404 ± 44 427 ± 43 406 ± 83 0.03 0.064 0.999 0.288 0.999 0.061 0.999
Oedema index
(% wet weight)
79 ± 3 78 ± 1 77 ± 1 79 ± 3 0.017 0.999 0.196 0.112 0.999 0.999 0.016
BW, body weight; RV, right ventricle; LV, left ventricle; VEH, autoclaved deionised water; ABX, antibiotic-treated; VEH-FMT, VEH followed by faecal microbiota transfer; ABX-FMT, anti-
biotic-treated followed by faecalmicrobiota transfer. Data are shown asmean± SDandwere statistically compared using one-wayANOVAwith Bonferroni post hocwhere appropriate, or
non-parametric Kruskal-Wallis test with Dunn's post hoc, where appropriate. Each p-value is adjusted to account for multiple comparisons. p-values shown in bold highlight significant
differences.
Table 2
Baseline ventilation, respiratory timing variability and metabolism in behaving rats during quiet rest.
VEH
(n= 10)
ABX
(n = 10)
VEH-FMT
(n = 10)
ABX-FMT
(n = 10)
One-way
ANOVA
VEH vs
ABX
VEH-FMT vs
ABX-FMT
VEH vs
VEH-FMT
ABX vs
ABX-FMT
VEH vs
ABX-FMT
ABX vs
VEH-FMT
fR(brpm) 83 ± 13 79 ± 11 79 ± 11 79 ± 14 0.845 – – – – – –
VE (ml/min/100 g) 50 ± 6 51 ± 8 48 ± 6 49 ± 7 0.855 – – – – – –
VT (ml/100 g) 0.63 ± 0.07 0.64 ± 0.12 0.61 ± 0.07 0.65 ± 0.06 0.763 – – – – – –
VT/Ti (ml/s/100 g) 2.5 ± 0.4 2.5 ± 0.6 2.5 ± 0.5 2.6 ± 0.4 0.936 – – – – – –
Ti (ms) 252 ± 23 264 ± 36 261 ± 26 259 ± 33 0.813 – – – – – –
Te (ms) 537 ± 96 557 ± 86 527 ± 101 565 ± 132 0.844 – – – – – –
Ti SD1 (ms) 29 ± 9 24 ± 7 28 ± 11 24 ± 6 0.484 – – – – – –
Ti SD2 (ms) 47 ± 20 43 ± 14 50 ± 20 37 ± 11 0.415 – – – – – –
VO2 (ml/min/100 g) 2.7 ± 0.6 3.3 ± 1.0 3.2 ± 0.7 3.0 ± 0.9 0.414 – – – – – –
VCO2 (ml/min/100
g)
1.6 ± 0.3 1.8 ± 0.2 1.8 ± 0.2 1.7 ± 0.3 0.093 – – – – – –
VE/VCO2 33 ± 6 30 ± 7 27 ± 2 29 ± 3 0.042 0.999 0.999 0.032 0.999 0.437 0.700
fR, respiratory frequency (brpm, breaths per min); VE, minute ventilation; VT, tidal volume; VT/Ti, mean inspiratory flow; Ti, inspiratory time; Te, expiratory time; SD1, short-term respira-
tory timing variability; SD2, long-term respiratory timing variability VO2, oxygen consumption; VCO2, carbon dioxide production; VE/VCO2, ventilatory equivalent; VEH, autoclaved
deionised water; ABX, antibiotic-treated; VEH-FMT, VEH followed by faecal microbiota transfer; ABX-FMT, antibiotic-treated followed by faecal microbiota transfer. Data are shown as
mean ± SD and were statistically compared using one-way ANOVA with Bonferroni post hoc where appropriate, or non-parametric Kruskal-Wallis test, where appropriate. Each p-
value is adjusted to account for multiple comparisons. p-values shown in bold highlight significant differences.
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significant (p= .093, two-way ANOVA, Fig. 2l), with values for VCO2
during hypercapnia equivalent between groups (data not shown).
Manipulation of the gut microbiota had a significant depressant effect
on ventilatory drive to breathe (VT/Ti) in response to hypercapnic
challenge (Table 5). No other ventilatory differences were noted be-
tween groups (Supplementary Fig. 5 b-d and Table 5). Repeated
measures two-way ANOVA was performed for ventilatory and meta-
bolic responsiveness to hypercapnia revealing that FMT significantly
decreased VE (gas, p b .0001; FMT, p= .014; gas x FMT, p= .043; re-
peated measures two-way ANOVA, Supplementary Fig. 2g), fR (gas, p
b .0001; FMT, p= .046; gas x FMT, p= .103; repeated measures two-
way ANOVA, Supplementary Fig. 2c) and VE/VCO2 (gas, p b .0001;
FMT, p= .003; gas x FMT, p= .048; repeated measures two-way
ANOVA, Supplementary Fig. 2k) in VEH-FMT rats compared with
VEH rats. Repeated measures two-way ANOVA revealed no difference
for VE, fR, and VE/VCO2 in ABX rats compared with ABX-FMT (Supple-
mentary Fig. 2d, h, i). Similarly, no differences were observed for
values in ABX-FMT rats compared with VEH-FMT rats (Fig. 2e, I, m;
p N .05; two-way ANOVA).
3.5. Respiratory timing variability, apnoeas and sighs during hypoxia and
hypercapnia in behaving rats during quiet rest
Assessments of short-term (SD1) and long-term (SD2) respiratory
timing variability for Ti, Te and Ttot in response to hypoxia (Table 4)
and for Te and Ttot in response to hypercapnia (Table 6)were equivalent
between groups. Ti SD2 in hypercapnia was altered by microbiota ma-
nipulation (Table 6). There was no difference in apnoea index or sigh
frequency (Tables 4 and 6) between groups. Furthermore, the average
duration of apnoeas during hypercapnia (Table 6) was equivalent be-
tween groups.
3.6. Cardiorespiratory recordings in anaesthetised rats
3.6.1. Baseline cardiorespiratory and blood gas parameters
Baseline cardiorespiratory and blood gas measurements in
anaesthetised rats are shown in Table 7. There were no significant dif-
ferences for baseline respiratory parameters between groups. Arterial
blood oxygenation, pH and carbon dioxide and bicarbonate concentra-
tionwere equivalent across groups. Haematocrit and haemoglobin con-
centrations were significantly lower in ABX rats compared with VEH
rats.Manipulation of the gutmicrobiota lowered systolic blood pressure
(Table 7). Post hoc analysis revealed that systolic blood pressurewas sig-
nificantly lower in ABX rats compared with VEH, VEH-FMT and ABX-
FMT rats but nodifference inmean arterial blood pressurewas observed
between groups (Table 7).
3.6.2. Cardiorespiratory responses to 5-HT3 receptor agonism evoking the
cardiopulmonary reflex
Stimulation, using PBG, of 5-HT3 receptors found on pulmonary
vagal afferent nerves evoked the integrated cardiopulmonary reflex
with no significant difference in apnoea duration in ABX rats compared
with VEH rats (p N .05, two-way ANOVA, Fig. 4b), or in ABX-FMT rats
comparedwith VEH-FMT rats (p N .05, two-way ANOVA, Fig. 4f). A sim-
ilar outcome was determined for post-apnoea induced tachypnoeic ep-
isodes in ABX rats compared with VEH rats (p N .05, two-way ANOVA,
Fig. 4c), and ABX-FMT rats compared with VEH-FMT rats (p N .05,
two-way ANOVA, Fig. 4g). The depressor response to PBG administra-
tion (hypotension) and bradycardia were also equivalent between
ABX rats and VEH rats (p N .05, two-way ANOVA, Fig. 4d, e) and in
ABX-FMT rats compared with VEH-FMT rats (p N .05, two-way
ANOVA, Fig. 4h, i). The cardiorespiratory responses to high-dose PBG
were abolished following bilateral cervical vagotomy.
3.7. Brainstem neurochemistry
L-DOPA, DA, HVA, HVA/DA ratio, 5-HT and 5-HIAA concentrations in
the brainstemwere significantly affected bymanipulation of the gutmi-
crobiota (p b .05; one-way ANOVA or Kruskal-Wallis, Fig. 5). Addition-
ally, post hoc analysis revealed that compared with VEH, ABX
brainstem homogenates contained elevated concentrations of L-DOPA
(p= .009; Kruskal-Wallis with Dunn's post hoc, Fig. 5a) and an in-
creased HVA/DA ratio (p= .0001; one-way ANOVA with Bonferroni
post hoc, Fig. 5d), a consequence of augmented HVA concentrations (p
b .0001, one-way ANOVA with Bonferroni post hoc, Fig. 5c) and de-
creased DA concentrations (p= .025; one-way ANOVAwith Bonferroni
post hoc, Fig. 5b). ABX-FMT samples comparedwith VEH, ABX and VEH-
FMT brainstem homogenates had significant increases in HVA/DA ratio
(p b .0001; p= .001; p= .0001, respectively; one-way ANOVA with
Bonferroni post hoc, Fig. 5d) due to elevated HVA concentrations (p b
.0001; p= .003; p= .0002, respectively; one-way ANOVA with
Bonferroni post hoc, Fig. 5c). L-DOPAwas elevated in ABX-FMT rats com-
pared with VEH and VEH-FMT brainstem homogenates (p= .001; p=
.038, respectively, Kruskal-Wallis with Dunn's post hoc, Fig. 5a). Further-
more, ABX-FMT contained increased concentrations compared with
VEH of 5-HT (p= .021; one-way ANOVA with Bonferroni post hoc, Fig.
5f) and 5-HIAA (p= .01; one-way ANOVA with Bonferroni post hoc,
Fig. 5g) along with a decrease in DA concentration (p= .0009; one-
way ANOVA with Bonferroni post hoc, Fig. 5b). VEH-FMT brainstem ho-
mogenates compared with VEH had elevated HVA/DA ratio (p= .0005;
one-way ANOVAwith Bonferroni post hoc, Fig. 5d) due to an increase in
HVA (p= .0004; one-way ANOVA with Bonferroni post hoc, Fig. 5c).
3.8. Ex vivo intestinal macromolecular permeability
The distal ileum from ABX rats was significantly more permeable
compared with VEH rats: FITC flux was enhanced in ABX tissue com-
pared with VEH at the 120-min time point (p= .025, two-way
ANOVAwith Bonferroni post-hoc, Fig. 7a). However, no statistically sig-
nificant difference was detected in the permeability of the proximal
colon of ABX rats comparedwithVEH rats (p N .05; Fig. 7c). Permeability
was equivalent in both the distal ileum and proximal colon of ABX-FMT
rats compared with VEH-FMT rats (p N .05; Fig. 7b, d). Permeability of
the distal ileum, but not proximal colon, was increased in VEH-FMT
compared with VEH (Supplementary Fig. 6).
3.9. Alterations in the caecal microbiota
As expected, ABX rats had a significantly heavier caecum compared
with VEH rats (p= .002; Kruskal-Wallis with Dunn's post hoc, Fig. 6d).
Faecal microbiota transfer attenuated the effects of antibiotics on cae-
cum weight; ABX-FMT and VEH-FMT rat caecum weights were lighter
comparedwith ABX (p= .0001 and p= .03, respectively; Kruskal-Wal-
lis with Dunn's post hoc, Fig. 6d). DNA concentrations in caecal samples
from ABX rats were critically low, likely a result of depletion of bacteria
by the broad-spectrum antibiotic cocktail and thus below the level of
detection. This prevented a comparative analysis of microbiota compo-
sition and diversity as 16S rRNA sequencing was not possible in this
group. In the remaining groups, 16S rRNA sequencing identified around
130 bacterial genera from 46 families of 9 different phyla (Supplemen-
tary Tables 14–22). Themajority of the bacterial genera belonged to two
major phyla (Bacteroidetes and Firmicutes), which together comprise
95% (VEH), 90% (VEH-FMT) and 85% (ABX-FMT) of intestinal microbi-
ota. The analysis of alpha and beta diversities revealed that FMT proce-
dure significantly altered the microbiota composition in both VEH-FMT
and ABX-FMT rats as compared with VEH rats. There was a clear trend
towards enhanced species richness of caecal microbiota in VEH-FMT
andABX-FMT samples: number of observed species, Chao1 (an estimate
of total richness in a sample [48]) and phylogenetic whole tree diversity
(PD whole tree, an estimate of diversity based on structure and branch
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Fig. 2.Chronic antibiotic administration and faecal microbiota transfer blunts hypercapnic ventilation in behaving rats during quiet rest. a) Representative traces of typical respiratory flow
duringnormoxic, hypoxic and hypercapnic ventilation inVEH, ABX, VEH-FMT andABX-FMT rats; downward deflections represent inspiration. Groupdata for respiratory frequency (b, c, d,
e), minute ventilation (f, g, h, i) and ventilatory equivalent (j, k, l, m) during normoxia and in response to hypoxia (b, c, f, g, j, k) and hypercapnia (d, e, h, i, l,m) for VEH andABX (b, f, j, d, h,
l) andVEH-FMT andABX-FMT (c, g, k, e, i,m). VEH, autoclaved deionisedwater; ABX, antibiotic-treated; VEH-FMT, VEH followedby faecalmicrobiota transfer; ABX-FMT, antibiotic-treated
followed by faecal microbiota transfer. Data (b-m) are expressed as mean± SD during baseline, hypoxia and hypercapnia; n=10 for all groups. Groups were statistically compared by
two-way ANOVA with Bonferroni post hocwhere appropriate. P values are shown. ** p b .01, ABX versus VEH, Bonferroni post hoc test.
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Fig. 3. Chronic antibiotic administration and faecalmicrobiota transfer do not alter respiratory timing variability, or the prevalence of apnoeas and sighs in behaving rats during quiet rest.
Poincaré plots of breath-to-breath (BBn) and subsequent breath-to-breath (BBn+ 1) interval of expiratory duration (Te; a, c) and total breath duration (Ttot; b, d) for 200 consecutive
breaths for VEH and ABX (a, b) and VEH-FMT and ABX-FMT rats (c, d). Group data for Te short-term variability (SD1; e) and long-term variability (SD2; f) and Ttot SD1 (g) and SD2 (h)
in VEH, ABX, VEH-FMT and ABX-FMT rats during normoxia. Representative respiratory flow traces (downward deflections represent inspiration) illustrating a spontaneous sigh
followed by an apnoea (i), a spontaneous apnoea (j) and a spontaneous sigh (k). Group data of apnoea index (l), apnoea duration (m) and sigh frequency (n). VEH, autoclaved
deionised water; ABX, antibiotic-treated; VEH-FMT, VEH followed by faecal microbiota transfer; ABX-FMT, antibiotic-treated followed by faecal microbiota transfer. Groups (e-h, l-n)
are expressed as box and whisker plots (median, IQR and minimum to maximum values); n = 10 for all groups. Groups were statistically compared by one-way ANOVA or non-
parametric Kruskal-Wallis with Dunn's post hoc, where appropriate. $ p b .05, VEH-FMT versus VEH, Dunn's post hoc test.
626 K.M. O'Connor et al. / EBioMedicine 44 (2019) 618–638
2 4 8 16 32
0
5
10
15
20
2 4 8 16 32
0.0
0.2
0.4
0.6
0.8
1.0
2 4 8 16 32
-400
-300
-200
-100
0
100
2 4 8 16 32
0
5
10
15
20
2 4 8 16 32
0.0
0.2
0.4
0.6
0.8
1.0
2 4 8 16 32 
-80
-60
-40
-20
0
2 4 8 16 32
-400
-300
-200
-100
0
100 VEH
VEH-FMT
ABX-FMT
ABX
)gk/gµ(GBP)gk/gµ(GBP)gk/gµ(GBP)gk/gµ(GBP
PBG (µg/kg) PBG (µg/kg)PBG (µg/kg) PBG (µg/kg)
f.
2 4 8 16 32
-80
-60
-40
-20
0
50
150
-10
10
-200
200
0
100
90
100
B
10s
T
I
2
350
450R
B
Fig. 4. Chronic antibiotic administration and faecal microbiota transfer do not alter cardiorespiratory responses to phenylbiguanide administration in anaesthetised rats. a) Representative
traces of blood pressure (red indicatesmean value), heart rate, tracheal airflow, rawand integrated diaphragm (Dia) electromyogram (EMG) activity and arterial oxygen saturation (SaO2)
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g) normalised to baseline respiratory period in response to 2,4, 8, 16 and 32 μg/kg of PBG for VEH and ABX (b, c) and for VEH-FMT andABX-FMT rats (f, g). Absolute change inmean arterial
blood pressure (MAP; d, h) and heart rate (e, i) in response to 2,4, 8, 16 and 32 μg/kg of PBG for VEH and ABX (d, e) and for VEH-FMT and ABX-FMT rats (h, i). VEH, autoclaved deionised
water; ABX, antibiotic-treated; VEH-FMT, VEH followed by faecal microbiota transfer; ABX-FMT, antibiotic-treated followed by faecal microbiota transfer. Data (b-i) are expressed mean
± SD; VEH (n=8), ABX (n= 8), VEH-FMT (n=9) and ABX-FMT (n=10). Groups were statistically compared by two-way ANOVA for VEH and ABX and separately for VEH-FMT and
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Fig. 5. Chronic antibiotic administration and faecal microbiota transfer alter rat brainstem neurochemistry. Group data for L-3,4-dihydroxyphenylalanine (a), dopamine (b), homovanillic
acid (c), homovanillic acid/dopamine ratio (d), noradrenaline (e), serotonin (f), 5-hydroxyindole acetic acid (g) and 5-hydroxyindole acetic acid/serotonin ratio (h) inVEH, ABX, VEH-FMT
and ABX-FMT rats. VEH, autoclaved deionised water; ABX, antibiotic-treated; VEH-FMT, VEH followed by faecal microbiota transfer; ABX-FMT, antibiotic-treated followed by faecal
microbiota transfer. Data (a-h) are expressed as box and whisker plots (median, IQR and minimum to maximum values). VEH (n=10), ABX (n= 8), VEH-FMT (n= 9) and ABX-FMT
(n= 10). Groups were statistically compared by one-way ANOVA with Bonferroni post hoc or non-parametric Kruskal-Wallis with Dunn's post hoc, where appropriate. * p b .05, ** p b
.01, **** p b .0001, ABX versus VEH; $ p b .05, $$$ p b .001, VEH versus VEH-FMT; &p b .01, &&& p b .001, &&&& p b .0001, VEH versus ABX-FMT; # p b .05, ### p b .001, VEH-FMT versus
ABX-FMT; ^^ p b .01, ABX versus ABX-FMT; all post hoc tests.
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length of the phylogenetic tree in each sample [49]) indices were all in-
creased in these groups (Fig. 7a, p= .035, p= .043 and p= .004 be-
tween VEH-FMT versus VEH; p= .052 for parameters in ABX-FMT
versus VEH). However, only an increase in PD whole tree diversity in
VEH-FMT vs. VEH rats remained significant after adjustment for multi-
ple comparisons. Shannon and Simpson metrics of alpha diversity,
which take into account the evenness of species abundance, were less
affected by FMT. Further, PCoA analysis identified structural differences
across all three groups, with VEH-FMT and ABX-FMT rats clearly sepa-
rating from VEH rats (Fig. 7b, p= .001, PERMANOVA).
At the phyla level, VEH-FMT and ABX-FMT rat caecal contents
displayed a distinct shift towards an increase in Proteobacteria and
Cyanobacteriawith a decrease in Bacteroidetes andDeferribacteres com-
paredwithVEH rats (Supplementary Tables 14 and15). Fiveminor phyla
remained unchanged between VEH-FMT and ABX-FMT rats compared
with VEH rats (Supplementary Tables 14 and 15). The minor phyla
Verrucomicrobia and Saccharibacteria were significantly altered in
ABX-FMT rats compared with VEH-FMT rats (Supplementary Table 16).
An increase in the relative abundance of Proteobacteria in VEH-FMT
and ABX-FMT rats was primarily caused by a shift inHelicobacter bacte-
ria, a genus ofHelicobacteraceae family (Fig. 7c). Increased abundance of
Helicobacter in VEH-FMT rats comparedwith VEH rats appeared to be at
the expense of Parasutterella (Alcaligenaceae) and Enterobacter (Entero-
bacteriaceae), which both displayed a reduced relative abundance. The
Cyanobacteria shifts evident in VEH-FMT andABX-FMT ratswere attrib-
uted to an increase in Gastranaerophilales uncultured species.
Bacteroidales S24–7 uncultured bacteria, a dominant genus of S24–7
family, was the main source of Bacteroidetes reduction in VEH-FMT
rat caecal samples compared with VEH rats; nonetheless, an increase
in minor Bacteroidetes V2.1 Bac22 uncultured species was noted (Fig.
7c). The decrease in Bacteroidetes in the ABX-FMT rats was not related
to a compelling decrease in any one genus but rather small shifts in the
relative abundance of multiple genera. Similar to the VEH-FMT group, a
minor increase in Bacteroidetes V2.1 Bac22 uncultured bacterium was
detected in ABX-FMT rats. The decrease in Deferribacteres in VEH-FMT
and ABX-FMT rats compared with VEH rats was a consequence of a de-
crease inMucispirillum (Deferribacteraceae family). Although there was
no significant difference at the Firmicutes phylum level, VEH-FMT
rats showed an increase in uncultured bacterium and unidentified gen-
era from Clostridiales vadin BB60 family, Lachnoclostridium-10,
Lachnospiraceae uncultured, Flavonifractor, Ruminococcaceae UCG-013
compared with VEH. A decrease occurred in Bacillus, Lachnospiraceae
UCG-008, Tyzzerella and Ruminoclostridium-9 (Fig. 7c). In ABX-FMT
rats therewas an increase in Lachnoclostridium-10 and Ruminococcaceae
UCG-011 and a decrease in Bacillus, Streptococcus and Lachnospiraceae
UCG-008 compared with VEH rats. Furthermore, uncultured
Coriobacteriaceae bacteria from the Actinobacteria phylumwas reduced
in the VEH-FMT and ABX-FMT rats compared with VEH rats. The alter-
ations evident at phyla level in ABX-FMT rats compared with VEH-
FMT rats were not related to changes in highly abundant genera. None-
theless, there was a decrease in Streptococcus (Streptococcaceae),
Peptoclostridium (Peptococcaceae), Ruminococcaceae UCG-005
a.
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Fig. 6. Chronic antibiotic administration increases themacromolecular permeability of rat distal ileum. Group data for FITC flux in distal ileum (a, b) and proximal colon (c, d) in VEH and
ABX (a, c) and inVEH-FMT andABX-FMT rats (b, d). VEH, autoclaved deionisedwater; ABX, antibiotic-treated; VEH-FMT, VEH followed by faecalmicrobiota transfer; ABX-FMT, antibiotic-
treated followed by faecal microbiota transfer. Groups (a-d) showing baseline (0min), 60min and 120 min FITC flux for VEH (n=4–5), ABX (n=6), VEH-FMT (n=5) and ABX-FMT (n
= 4). Groups were statistically compared by two-way ANOVA with Bonferroni post hoc, where appropriate. * p b .05, ABX versus VEH.
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630 K.M. O'Connor et al. / EBioMedicine 44 (2019) 618–638
(Ruminococcaceae) compared with VEH-FMT rats. ABX-FMT rats
displayed an increase in Allobaculum (Erysipelotrichaceae) and
Parasutterella (Alcaligenaceae) from the phyla Firmicutes and
Proteobacteria, respectively (Fig. 7c).
3.10. Correlation analysis between microbiota composition and brainstem
neurochemistry and heart rate
Associations between genera and brainstem neurochemistry as well
as basal heart rate in VEH, VEH-FMT and ABX-FMT rats were identified
utilisingHierarchical All-against-All (HAllA) correlation analysis. Identi-
fied associations are presented as a correlogram in Fig. 8. Individual
data points for the most significant correlations for homovanillic,
homovanillic/dopamine and dopamine are presented as scatter plots
in Supplementary Fig. 7. Anaerovorax, a member of Firmicutes phylum
positively associated with basal heart rate. Further to this, several gen-
era from different phyla correlated with brainstem neurochemistry.
Peptoclostridium and Ruminococcaceae UCG-005 of Firmicutes phylum
negatively associated with L-DOPA. Lachnspiraceae (Eubacterium)
ventriosum group and Erysipelotrichaceae UCG-004 of Firmicutes posi-
tively associated with NA, while Coriobacteriaceae uncultured, a genus
of Actinobacteria negatively associatedwith NA.Helicobacter, amember
of Proteobacteria phylum as well as Bacteroidetes VC2.1 Bac22 uncul-
tured, a member of Bacteroidetes phylum negatively correlated with
DA. Bacillus, of Firmicutes phylum and Coriobacteriaceae uncultured
positively correlated with DA. Bacteroidetes VC2.1 Bac22 uncultured
Gastranaerophilales uncultured organism as well as 3 genera from
Firmicutes phylum, Ruminococcaceae UCG-011, Lachnoclostridium 10
and Clostridiales vadin BB60 group uncultured bacterium positively as-
sociated with HVA, whereas Bacillus and Mucispirillum, a member
of Deferribacteres phylum negatively associated with HVA.
Ruminococcaceae UCG-009, Lachnoclostrdium 10, Bacteroidetes VC2.1
Bac22uncultured and Burkholderia, amember of phylumProteobacteria
positively associated with HVA/DA turnover. Bacillus, Mucispirillum and
Coriobacteriaceae uncultured negatively associated with this ratio.
Lachnoclostridium 10 positively correlated with 5-HT. Ruminococcaceae
V9D2013 group, Clostridiales vadinBB60 group uncultured bacterium,
Gastranaerophilales uncultured bacterium and Bacteroidetes VC2.1
mulyhPsuneG
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Fig. 8. Brainstem neurochemistry and heart rate are associated with the abundance of specific genera. Hallagram depicting Spearman correlations between the relative abundance of
bacterial genera and brainstem neurochemistry as well as basal heart rate (VEH, VEH-FMT and ABX-FMT). Genera are ordered taxonomically. HR, heart rate; L-DOPA, L-3,4-
dihydroxyphenylalanine; NA, noradrenaline; DA, dopamine; HVA, homovanillic acid; HVA/DA, homovanillic acid/dopamine; 5-HT, serotonin; 5-HIAA, 5-hydroindole acetic acid; 5-
HIAA/5-HT, 5-hydroindole acetic acid/serotonin. Significant correlations are represented by black dots ( ). Benjamini-Hochberg adjustment p-value with Q= 0.2 was used to correct
p values for multiple testing.
Table 3
Ventilatory and metabolic responsiveness during hypoxia in behaving rats during quiet rest.
VEH (n = 10) ABX (n = 10) VEH-FMT (n = 10) ABX-FMT (n = 10) One-way ANOVA
Δ fR (brpm) 68 ± 20 63 ± 20 57 ± 21 65 ± 17 0.585
Δ VE (ml/min/100 g) 43 ± 8 36 ± 14 36 ± 9 43 ± 13 0.244
Δ VT (ml/100 g) 0.07 ± 0.08 0.06 ± 0.08 0.08 ± 0.06 0.02 ± 0.08 0.35
Δ VT/Ti (ml/s/100 g) 4.4 ± 0.7 4.1 ± 1.1 3.6 ± 0.7 4.1 ± 0.6 0.168
Δ Ti (ms) −87 ± 28 −95 ± 41 −87 ± 32 −92 ± 34 0.933
Δ Te (ms) −236 ± 62 −239 ± 78 −208 ± 72 −263 ± 106 0.153
Δ VO2 (ml/min/100 g) −1.0 ± 0.7 −1.4 ± 1.1 −0.9 ± 0.8 −0.86 ± 0.9 0.522
Δ VCO2 (ml/min/
100 g)
0.2 ± 0.5 −0.005 ± 0.3 0.09 ± 0.2 0.02 ± 0.2 0.444
Δ VE/VCO2 22 ± 10 20 ± 9 18 ± 6 24 ± 5 0.335
fR, respiratory frequency (brpm, breaths per min); VE, minute ventilation; VT, tidal volume; VT/Ti, mean inspiratory flow; Ti, inspiratory time; Te, expiratory time; SD1, short-term respira-
tory timing variability; SD2, long-term respiratory timing variability VO2, oxygen consumption; VCO2, carbon dioxide production; VE/VCO2, ventilatory equivalent; VEH, autoclaved
deionised water; ABX, antibiotic-treated; VEH-FMT, VEH followed by faecal microbiota transfer; ABX-FMT, antibiotic-treated followed by faecal microbiota transfer. Data are shown as
mean± SD and were statistically compared using one-way ANOVA with Bonferroni post hocwhere appropriate. Each p-value is adjusted to account for multiple comparisons. Data are
expressed as absolute change from baseline (Δ parameter).
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Bac22 uncultured, positively correlated with 5-HIAA. Natranaerovirga
negatively associated with 5-HIAA. Clostridiales Family XII UCG-001 neg-
atively associated with 5HIAA/5-HT.
4. Discussion
There is considerable interest in the role of the gut microbiota in
health and disease. This interest stems from established associations be-
tween the gutmicrobiota and brain behaviours [5,6,50–53]. Our interests
relate to the potential influence of the microbiota on the cardiorespira-
tory system. We sought to assess the effects of manipulation of the gut
microbiota by chronic antibiotic administration on cardiorespiratory
physiology inadultmale rats, and to investigate if faecalmicrobiota trans-
fer of pooled control faeces could reverse or ameliorate putative deleteri-
ous effects induced by chronic antibiotic administration (microbiota
disruption). The principal findings of this study are: 1) ABX and FMT
blunt the ventilatory response to hypercapnia due to decreased respira-
tory freuqency; 2) ABX and FMT blunt respiratory frequency during the
peakhypoxic ventilatory response; 3)neitherABXnor FMT interventions
alter respiratory timing variability; 4) ABX decreases systolic blood pres-
sure; 5) cardiorespiratory responsiveness to vagal afferentnerve stimula-
tion is unaffected by ABX or FMT; 6) ABX and FMT alter brainstem
monoamine and monoamine metabolite concentrations; 7) ABX and
FMT, increases distal ileum permeability; 8) FMT significantly altered
gut microbiota composition and diversity; 9) Genera from 6 phyla, pre-
dominantly Firmicutes, correlate with brainstem neurochemistry.
4.1. Animal model
4.1.1. Microbiota manipulation by chronic antibiotic administration
Two different approaches were used in this study to manipulate the
microbiota. First, we used an antibiotic cocktail, informed by previous
studies where microbiota depletion was successful [5,36]. Failure to de-
termine the caecal microbiota composition of ABX rats in the current
study was likely the result of severe microbiota depletion and substan-
tially diminished available bacterial DNA for detection. This was further
supported by the dramatic enlargement of the caecum in ABX rats; an
increase in caecummass results from the loss of bacterial fermentation,
consistent with previous observations both in germ-free and antibiotic-
treated animals [54,55]. Faecal output in ABX rats was qualitatively de-
termined as having an increased water composition, a frequent compli-
cation of antibiotic administration [55]. We postulate that altered
defaecation may have resulted from antibiotic-induced microbiota de-
pletion and potential expansion of opportunistic bacteria [56].
4.1.2. Faecal microbiota transfer significantly altered gut microbiota com-
position and diversity
In addition to ABX, we utilised a FMT strategy to manipulate gut mi-
crobiota. It has been shown that behavioural phenotypes can be trans-
ferred via FMT in rodents [5,57–59]. The FMT strategy used in our
study did not recover or normalise the microbiota composition. VEH-
FMT and ABX-FMT groups both displayed profound changes in microbi-
ota structure and species diversity comparedwith the VEH group. Caecal
samples from VEH-FMT and ABX-FMT animals had the relative abun-
dance of 18 and 10 genera altered, respectively, compared with VEH an-
imals. Only 5 genera were significantly different between VEH-FMT and
ABX-FMT. Our findings are consistent with recent clinical data where
FMT to persons with irritable bowel syndrome led to the establishment
of unique taxonomy as well as increased diversity with no improvement
in symptoms [60]. Pooled exogenous bacteria has been shown to in-
crease microbiota diversity in recipient rats, resembling that of the
donor [61]. However, pre-treatment with antibiotics does not facilitate
establishment of the donor microbiota [61]. Interestingly, autologous
FMT had no effect on insulin sensitivity in obese metabolic syndrome,
Table 4
Respiratory timing variability, apnoeas and sighs during hypoxia in behaving rats during quiet rest.
VEH (n = 10) ABX (n = 10) VEH-FMT (n = 10) ABX-FMT (n = 10) One-way ANOVA
Ti SD1 (ms) 28 ± 5 30 ± 6 30 ± 6 29 ± 7 0.744
Ti SD2 (ms) 57 ± 10 67 ± 19 59 ± 9 57 ± 16 0.272
Te SD1 (ms) 79 ± 28 89 ± 35 77 ± 15 80 ± 31 0.804
Te SD2 (ms) 140 ± 27 147 ± 32 132 ± 37 130 ± 42 0.699
Ttot SD1 (ms) 102 ± 31 112 ± 38 99 ± 15 102 ± 33 0.803
Ttot SD2 (ms) 217 ± 30 237 ± 35 217 ± 32 203 ± 64 0.405
Apnoea index (events/h) 0.6 ± 1.9 3.0 ± 4.2 1.2 ± 2.5 1.2 ± 2.5 0.398
Sigh frequency (events/h) 148 ± 35 166 ± 71 172 ± 46 160 ± 29 0.715
Ti, inspiratory time; Te, expiratory time; Ttot, total breath duration; SD1, short-term respiratory timing variability; SD2, long-term respiratory timing variability; VEH, autoclaved deionised
water; ABX, antibiotic-treated; VEH-FMT, VEH followed by faecal microbiota transfer; ABX-FMT, antibiotic-treated followed by faecal microbiota transfer. Data are shown as mean± SD
and were statistically compared using one-way ANOVA or non-parametric Kruskal-Wallis test where appropriate.
Table 5
Ventilatory and metabolic responsiveness during hypercapnia in behaving rats during quiet rest.
VEH
(n = 10)
ABX
(n = 10)
VEH-FMT
(n = 10)
ABX-FMT
(n = 10)
One-way
ANOVA
VEH
vs
ABX
VEH-FMT
vs
ABX-FMT
VEH vs
VEH-FMT
ABX vs
ABX-FMT
VEH vs
ABX-FMT
ABX vs
VEH-FMT
Δ fR (brpm) 86 ± 52 45 ± 29 56 ± 15 53 ± 18 0.038 0.043 0.999 0.281 0.999 0.164 0.999
Δ VE (ml/min/100 g) 67 ± 33 39 ± 23 42 ± 15 42 ± 14 0.02 0.045 0.999 0.091 0.999 0.066 0.999
Δ VT (ml/100 g) 0.15 ± 0.12 0.11 ± 0.16 0.08 ± 0.07 0.07 ± 0.06 0.33 – – – – – –
Δ VT/Ti (ml/s/100 g) 4.7 ± 1.6 3.1 ± 1.3 2.9 ± 1.0 3.0 ± 0.8 0.028 0.131 0.999 0.059 0.999 0.082 0.999
Δ Ti (ms) −75 ± 42 - 46 ± 33 −58 ± 35 −49 ± 30 0.253 – – – – – –
Δ Te (ms) −273 ± 133 −250 ± 116 −261 ± 97 −281 ± 103 0.961 – – – – – –
Δ VO2 (ml/min/100 g) −1.4 ± 0.8 −1.9 ± 1 −1.5 ± 1.1 −1.5 ± 0.9 0.69 – – – – – –
Δ VCO2 (ml/min/100 g) −0.2 ± 0.4 −0.3 ± 0.5 −0.2 ± 0.6 −0.2 ± 0.5 0.886 – – – – – –
Δ VE/VCO2 59 ± 30 35 ± 31 36 ± 18 38 ± 18 0.115 – – – – – –
fR, respiratory frequency (brpm, breaths per min); VE, minute ventilation; VT, tidal volume; VT/Ti, mean inspiratory flow; Ti, inspiratory time; Te, expiratory time; SD1, short-term respira-
tory timing variability; SD2, long-term respiratory timing variability VO2, oxygen consumption; VCO2, carbon dioxide production; VE/VCO2, ventilatory equivalent; VEH, autoclaved
deionised water; ABX, antibiotic-administration; VEH-FMT, VEH followed by faecal microbiota transfer; ABX-FMT, antibiotic administration followed by faecal microbiota transfer. Data
are shown as mean± SD and were statistically compared using one-way ANOVA with Bonferroni post hoc where appropriate, or non-parametric Kruskal-Wallis test with Dunn's post
hoc, where appropriate. Each p-value is adjusted to account formultiple comparisons. p-values shown in bold highlight significant differences. Responses are expressed as absolute change
from baseline (Δ parameter).
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however allogenic FMT had transient benefits on insulin sensitivity
which was driven by baseline faecal microbiota composition [62].
Caecumweights of ABX-FMT rats were lighter than that of ABX rats,
but did not recover completely to VEH values. After discontinuing anti-
biotic exposure, gastrointestinal responses of ABX-FMT rats, assessed
qualitatively by faecal output, returned to levels equivalent to VEH
rats. Similar results were observed both in rodent and clinical studies
where FMT was used to treat Clostridium difficile infection and sepsis
[58,63]. Thus, ABX-induced alterations to the microbiota were not re-
versed by FMT intervention in our study. Indeed, FMT itself led to signif-
icant modification of the microbiota, establishing a separate model of
microbiota disruption in our study (VEH-FMT and ABX-FMT groups),
with distinct microbiota signatures comparedwith that of VEH animals.
4.2. Chronic antibiotic administration and faecal microbiota transfer blunt
ventilatory responses to hypoxia and hypercapnia
To date few studies have examined the consequences of manipu-
lation of the gut microbiota on the control of breathing. We
previously revealed enhanced variability of breathing frequency dur-
ing normoxic breathing, and altered ventilation during hypoxic and
hypercapnic chemostimulation in adult rats exposed to antecedent
pre-natal stress [15]. Significant correlations were found between re-
spiratory frequency during hypercapnia and bacterial genera of the
Firmicutes phylum [15], suggesting a potential influence of alter-
ations in the gut microbiota on the control of respiratory rhythm
during CO2 exposure.
We reasoned that perturbation of the gut microbiota by ABX would
elicit a distinctive respiratory control signature. In conscious behaving
rats during quiet rest, no apparent aberrant respiratory control pheno-
type was evident in ABX rats during normoxia such that we observed
normal values for ventilation andmetabolism equivalent to VEH.More-
over, VEH-FMT and ABX-FMT rats were similar to VEH revealing the re-
markable capacity of the neural network tomaintain homeostasis in the
light of major disruption to brainstem monoamine concentrations
(discussed below). VE/VCO2 was decreased in VEH-FMT rats compared
with VEH during normoxia, revealing a relatively depressed level of
ventilation per se in VEH-FMT rats.
Table 6
Respiratory timing variability, apnoeas and sighs during hypercapnia in behaving rats during quiet rest.
VEH
(n = 10)
ABX
(n = 10)
VEH-FMT
(n = 10)
ABX-FMT
(n = 10)
One-way
ANOVA
VEH vs
ABX
VEH-FMT
vs
ABX-FMT
VEH vs
VEH-FMT
ABX vs
ABX-FMT
VEH vs
ABX-FMT
ABX vs
VEH-FMT
Ti SD1 (ms) 24 ± 6 18 ± 8 17 ± 5 17 ± 4 0.042 0.232 0.999 0.091 0.999 0.083 0.999
Ti SD2 (ms) 55 ± 27 29 ± 14 30 ± 11 36 ± 10 0.004 0.006 0.999 0.019 0.701 0.511 0.999
Te SD1 (ms) 28 ± 46 54 ± 27 53 ± 29 51 ± 22 0.697 – – – – – –
Te SD2 (ms) 109 ± 55 73 ± 32 78 ± 34 76 ± 28 0.329 – – – – – –
Ttot SD1 (ms) 80 ± 29 64 ± 31 62 ± 26 61 ± 24 0.375 – – – – – –
Ttot SD2 (ms) 161 ± 88 108 ± 51 103 ± 36 94 ± 41 0.170 – – – – – –
Apnoea index
(events/h)
5.5 ± 5.5 9.5 ± 5.5 11.0 ± 6.1 12.0 ± 8.6 0.159 – – – – – –
Apnoea duration (s) 2.3 ± 1.0 2.5 ± 0.8 2.2 ± 0.5 2.2 ± 0.7 0.689 – – – – – –
Sigh frequency
(events/h)
14 ± 6 14 ± 5 15 ± 7 19 ± 11 0.87 – – – – – –
Ti, inspiratory time; Te, expiratory time; Ttot, total breath duration; SD1, short-term respiratory timing variability; SD2, long-term respiratory timing variability; VEH, autoclaved deionised
water; ABX, antibiotic-treated; VEH-FMT, VEH followed by faecal microbiota transfer; ABX-FMT, antibiotic-treated followed by faecal microbiota transfer. Data are shown as mean± SD
andwere statistically compared using one-way ANOVAwith Bonferroni post hocwhere appropriate, or non-parametric Kruskal-Wallis test with Dunn's post hoc, where appropriate. Each
p-value is adjusted to account for multiple comparisons. p-values shown in bold highlight significant differences.
Table 7
Baseline ventilation, blood gases and cardiovascular measurements in anaesthetised rats.
VEH
(n = 8–10)
ABX
(n= 8)
VEH-FMT
(n = 9)
ABX-FMT
(n = 10)
One-way
ANOVA
VEH
vs
ABX
VEH-FMT
vs
ABX-FMT
VEH vs
VEH-FMT
ABX vs
ABX-FMT
VEH vs
ABX-FMT
ABX vs
VEH-FMT
fR(brpm) 99 ± 13 103 ± 9 92 ± 14 88 ± 12 0.066 – – – – – –
VE (ml/min/ 100
g)
35.9 ± 3.7 36.3 ± 4.6 31.6 ± 6.7 30.2 ± 12 0.071 – – – – – –
VT (ml/ 100 g) 0.36 ± 0.03 0.35 ± 0.04 0.34 ± 0.05 0.38 ± 0.06 0.312 – – – – – –
ETCO2 5.9 ± 0.6 5.9 ± 0.9 5.6 ± 0.6 5.6 ± 0.6 0.536 – – – – – –
pH 7.34 ± 0.02 7.36 ± 0.06 7.36 ± 0.03 7.37 ± 0.03 0.272 – – – – – –
PaCO2 (mmHg) 48.2 ± 3.9 47.2 ± 7.9 48.6 ± 5.2 45.2 ± 4.3 0.272 – – – – – –
PaO2 (mmHg) 107 ± 16 100 ± 8 106 ± 10 104 ± 6 0.712 – – – – – –
[HCO3−] (mmol/ l) 26.3 ± 1.2 26.4 ± 2.0 27.1 ± 1.4 26.1 ± 0.9 0.106 – – – – – –
TCO2 (mmol/l) 27.7 ± 1.3 27.8 ± 2.4 28.3 ± 1.5 27.5 ± 1.0 0.303 – – – – – –
SaO2 (%) 97.5 ± 1.1 97.3 ± 0.9 97.7 ± 0.7 97.6 ± 0.7 0.987 – – – – – –
[Na+] (mmol /l) 136.6 ± 2.6 137.0 ± 1.8 135.4 ± 1.4 135.1 ± 1.4 0.078 – – – – – –
[K+] (mmol/l) 4.2 ± 0.1 4.0 ± 0.2 4.2 ± 0.1 4.2 ± 0.2 0.149 – – – – – –
Haematocrit (%) 51.7 ± 2.9 47.9 ± 2.0 48.3 ± 2.9 49.7 ± 2.3 0.016 0.024 0.999 0.062 0.665 0.792 0.999
[Hb] (g/dl) 17.5 ± 0.9 16.3 ± 0.7 16.1 ± 1.4 16.1 ± 2.9 0.021 0.028 0.999 0.082 0.999 0.596 0.999
MAP (mmHg) 96 ± 9 93 ± 12 90 ± 10 94 ± 13 0.712 – – – – – –
DBP (mmHg) 73 ± 9 74 ± 13 66 ± 7 70 ± 12 0.463 – – – – – –
SBP (mmHg) 148 ± 15 119 ± 12 140 ± 15 147 ± 15 0.0005 0.0007 0.999 0.999 0.001 0.999 0.024
HR (bpm) 410 ± 29 407 ± 40 389 ± 27 410 ± 28 0.438 – – – – – –
fR, respiratory frequency (brpm, breaths per min); VE, minute ventilation; VT, tidal volume; ETCO2, end-tidal carbon dioxide production; PaCO2, partial pressure of arterial carbon dioxide;
PaO2, partial pressure of arterial oxygen; [HCO3−], bicarbonate concentration; TCO2, total carbon dioxide; SaO2, arterial oxygen saturation; [Na+], sodium concentration; [K+], potassium
concentration; [Hb], haemoglobin concentration;MAP,mean arterial blood pressure; SBP, systolic blood pressure; DBP, diastolic blood pressure; HR, heart rate (bpm, beat permin); dP/dt
max, maximum left ventricular contractility; PP, pulse pressure; VEH, autoclaved deionised water; ABX, antibiotic-treated; VEH-FMT, VEH followed by faecal microbiota transfer; ABX-
FMT, antibiotic-treated followed by faecal microbiota transfer. Data are shown as mean± SD and were statistically compared using one-way ANOVAwith Bonferroni post hocwhere ap-
propriate, or non-parametric Kruskal-Wallis test with Dunn's post hoc,where appropriate. Each p-value is adjusted to account for multiple comparisons. p-values shown in bold highlight
significant differences.
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Compared with VEH, ABX depressed the peak hypoxic ventilatory
response and respiratory frequency component of the response during
the first 2 min of exposure to hypoxia. A similar bluntedminute ventila-
tion and frequency response was observed in VEH-FMT rats compared
with VEH revealing a consistent outcome in response to manipulation
of the gut microbiota. Interestingly, respiratory timing variability was
unaffected by ABX or FMT. Moreover, analysis of steady-state responses
during the last 5 min of hypoxic exposure revealed that there was no
aberrant respiratory phenotype evident in ABXor FMT rats. Our findings
in ABX and FMT rats of a bluntedminute ventilation and respiratory fre-
quency response in phase 1 of the hypoxic ventilatory response is sim-
ilar to the depressed hypoxic ventilatory response evident in adult rats
exposed to pre-natal stress, where a significantly depressed respiratory
frequency response to hypoxia was also observed [15]. It is plausible
that manipulation of the gut microbiota resulted in altered integration
of chemosensory inputs from the carotid bodies (theprimary peripheral
oxygen sensors) at the level of the nucleus tractus solitarius, leading to
the development of a blunted frequency response to hypoxia. It is in-
triguing to consider that microbiota disruption may have resulted in
re-programming of the carotid bodies, resulting in modified
chemosensory afferent discharge to the brain, but this remains to be
tested in future work. Although the peak hypoxic ventilatory response
was blunted, the steady-state response (phase 2) was intact, again
highlighting the robust capacity of the chemoreflex pathway in main-
taining respiratory homeostasis in our models.
Chemoactivation of ventilation in response to hypercapnic stress
(elevated inspired CO2) revealed a robust blunted VE response to CO2
challenge in ABX rats compared with VEH, a ventilatory depression
manifest as a reduced fR response to hypercapnia (bradypnoea),
which was maintained throughout the hypercapnic challenge. Manipu-
lation of the gut microbiota had no effect on metabolic responses
(VCO2) to hypercapnia. Thus, the ventilatory equivalent for carbon diox-
ide (VE/VCO2), which relates ventilation to the prevailing metabolism,
was depressed in ABX rats compared with VEH rats, highlighting inade-
quate ventilation to meet metabolic demand (hypoventilation). Micro-
biota disruption by FMT resulted in decreased ventilation in
hypercapnia in FMT groups to levels similar to that seen in ABX animals,
and significantly below that of VEH rats. Therefore, two modes of
disrupted microbiota in our study were associated with depressed ven-
tilatory response to hypercapnia. Respiratory timing variability and as-
sociated respiratory behaviours such as apnoeas and sighs were
essentially unaffected by microbiota manipulation.
The disruptions to ventilation in response to hypoxic or hypercapnic
stress observed in behaving animals using whole-body plethysmogra-
phy, were not evident in urethane-anaesthetised animals, suggesting
that the changes in respiratory control may be state-dependent [64]. In-
deed anaesthesia depresses respiratory drive and chemoresponsiveness
[65], and this may have masked the otherwise blunted ventilatory re-
sponsiveness to hypercapnic stress and the blunted peak ventilatory re-
sponse to hypoxia in animals with manipulations to the microbiota.
Alternatively, it may be that chemoreflex-driven homeostatic control
of breathing is unaffected in ABX and FMT rats, but that the composite
behavioural response to hypoxic and hypercapnic stress—manifest in
the integrated respiratory behavioural response to challenges—is
blunted.
The hypercapnic stimulus used in our study was modest, sufficient
to evoke a ventilatory response through the activation of central ner-
vous system CO2 chemoreceptors, but not intended as an overt behav-
ioural stressor. Nevertheless, hypercapnia can provoke fear-associated
responses and there are strong links between emotion and respiratory
behaviour. Indeed, ventilatory hypersensitivity to CO2 is a hallmark of
panic disorder in susceptible individuals. Thus, it is possible in our
study that manipulation of the microbiota altered neurochemistry in
brain regions such as the amygdala [36], which is known to modulate
ventilatory responsiveness to CO2 [66]. Dopamine is a candidate neuro-
transmitter in emotion-associated respiratory control, with evidence
that breathing is modulated by dopaminergic signalling in the
basolateral amygdala [67]. The data from behaving rats demonstrate a
capacity for aberrant respiratory plasticity in animals with altered gut
microbiota, supporting the concept that the microbiota-gut-brainstem
axis may function as an important modulator of the respiratory control
network, either directly or indirectly. Blunted CO2 chemoreflex ventila-
tory responses are physiologically significant as they increase the risk of
the development of systemic acidosis in circumstances of elevated CO2
(e.g. sleep, pulmonary and respiratory control diseases, respiratory de-
pression by drugs) [68,69]. Hypercapnic acidosis can compromise the
function of neural networks and systemic tissues due to pH imbalance.
As such, disruptions to the microbiota could via aberrant respiratory
control, exert deleterious effects on whole body homeostasis.
4.3. Chronic antibiotic administration decreases systolic blood pressure
Cardiovascular control is complex and multifaceted with recent
studies in animal models and humans demonstrating the contribution
of the gut microbiome to the regulation of blood pressure [14,34,35].
In spontaneously hypertensive rat and angiotensin-II hypertensive rat
models, shifts in microbiota richness and increases in the Firmicutes:
Bacteroidetes ratio are evident [35]. Of note, FMT from hypertensive
human donors to germ-free mice elevates blood pressure in the recipi-
ent mice, which was observed to be transferrable through the microbi-
ota [34]. Similarly, it has been demonstrated that antibiotic-treated
normotensive rats that received a FMT of donor faeces from hyperten-
sive rats subsequently developed hypertension [14]. Bacterial metabo-
lites are associated with the development of high blood pressure;
specifically, a decrease in butyrate-producing and acetate-producing
bacteria, which promote intestinal barrier integrity, and an increase in
lactate-producing bacteria are each associated with hypertension
[12,14,35]. Oral administration of a probiotic (Clostridium butyricum)
or a prebiotic (Hylon VII) prevented microbiota disruption, increased
acetate levels and prevented the development of hypertension in a rat
model of obstructive sleep apnoea [17]. Additionally, caecal acetate ad-
ministration prevented obstructive sleep apnoea induced hypertension
[17]. The anti-inflammatory antibiotic minocycline was shown to ame-
liorate hypertension and reduce the Firmicutes:Bacteroidetes ratio in an
angiotensin II hypertensive rat model [35]. The absence of gut microbi-
ota in germ free mice appears to be protective against angiotensin II in-
duced hypertension and vascular dysfunction [70]. Our study revealed
that chronic broad-spectrum ABX intervention results in lower systolic
blood pressure and pulse pressure, although no difference was evident
in mean arterial blood pressure.
Evidence is accruing in support of a microbial influence over cardio-
vascular control although a defined microbiota signature essential to
the maintenance of normal blood pressure has yet to be determined.
An enrichment in Lactobacillus, Bifidobacterium and Allobaculum along
with a reduction in Lachnospiraceae, Lactococcus, Blautia, Coprobacillus
and Erysipelotrichaceae species occurred in a rat model of obstructive
sleep apnoea compared with sham. In sham animals, prebiotic (Hylon
VII) treatment increased the abundance of acetate-producing genera,
including Blautia, Colinsella, Bifidobacterium and Ruminococcus,
preventing the development of hypertension [17]. Intriguingly, a dra-
matic proliferation of certain genera such as Prevotella and Klebsiella
has been shown both in pre-hypertensive and hypertensive
individuals compared with normotensive controls. In this clinical popu-
lation, Firmicutes including Oscillibacter, Roseburia and Blautia,
Bifidobacterium from Actinobacteria phylum and Akkermansia from
Verrucomicrobiaceae phylum were 5 out of 11 genera enriched in
healthy normotensive controls compared with pre-hypertensive and
hypertensive individuals [34]. Indeed, these genera were in the top
45% of highly abundant genera in VEH, VEH-FMT and ABX-FMT groups.
Generawhichwere highly abundant in pre-hypertensive and hyperten-
sive humanswere not abundant in this study, but comparisons between
species may not be appropriate. Of interest, Blautia and Bifidobacterium
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were highly abundant in prebiotic-treated normotensive rodents and
healthy normotensive controls [17,34]. These acetate-producing bacte-
rial taxa may have a role in the regulation of normal blood pressure
[15]. Correlation analysis in our study revealed no associations between
genera and blood pressure parameters. However, Anaerovorax, of
Firmicutes phylum positively correlated with basal heart rate.
4.4. Cardiorespiratory responsiveness to vagal afferent nerve stimulation is
unaffected chronic antibiotic administration and faecal microbiota transfer
The afferent vagal pathway provides crucial signalling between the
gut microbiota and the central nervous system [71]. Alterations in gut
microbiota composition or diversity, resulting in differential production
of bacterial metabolites, have been shown to influence afferent vagal
traffic [20,72]. Vagal afferents innervate the nucleus tractus solitarius,
a critical relay hub in the integration of cardiorespiratory control [73].
The 5-HT3 receptor agonist, PBG, stimulates pulmonary vagal afferent
C-fibres manifesting the classical chemoreflex characterised by apnoea
and post-apnoea tachypnoea, bradycardia and a fall in blood pressure
[43,44]. Manipulation of the gut microbiota could conceivably manifest
abnormal vagal afferent signalling and aberrant central processing of
sensory inputs. However, in our study, there was no difference in the
cardiorespiratory efferent responses to PBG challenge. We conclude
that manipulation of the microbiota by ABX and FMT interventions
does not alter the cardiorespiratory response to the vagal afferent pul-
monary C-fibre stimulation, notwithstanding evidence of significant
disruptions in brainstem monoamine concentrations. Whereas PBG
can also induce neurotransmitter release centrally in the nucleus ac-
cumbens [74] and the nucleus tractus solitarius [75], we confirmed in
our study that cardiorespiratory effects were mediated exclusively by
vagal afferent feedback since responses were abolished following bilat-
eral cervical vagotomy. Examination of vagal afferent activation from
other peripheral sites, notably the gut, was not performed in this
study, but would be interesting to determine in future work.
4.5. Chronic antibiotic administration and faecal microbiota transfer alter
brainstem monoamine and monoamine metabolite concentrations
We examined the concentrations of brainstem monoamines impor-
tant in the neuromodulation of cardiorespiratory control with a partic-
ular interest in monoamines and metabolites that play a role in central
chemoreception. Significant disruptions to monoamine, monoamine
precursor and metabolite concentrations were determined in the
brainstem of ABX and FMT rats, an outcome that coincides with de-
pressed hypercapnic ventilation.
Noradrenaline is a potent modulator of breathing [76,77]. We found
no change in brainstem noradrenaline concentration between groups.
5-HT is a pivotal neuromodulator of the respiratory motor network
and primarily has an excitatory effect on breathing [78]. It is well
established that pharmacological manipulation of serotonergic signal-
ling affects respiratory motor output [79,80]. Transgenic mice lacking
central 5-HT neurons show a significant reduction in the hypercapnic
ventilatory response [81–83] and lesions of raphé serotonergic neurons
decrease the respiratory response to hypercapnia [84]. Pharmacological
manipulation of 5-HT affects ventilation and arousal during hypercap-
nia [85,86]. Our data revealed a blunted ventilatory response to hyper-
capnia in ABX rats. However, 5-HT concentrations were not changed
in ABX rats, thus, it is not likely that 5-HT is implicated in the depressed
ventilatory responsiveness observed in ABX rats. 5-HT concentrations
were significantly increased in ABX-FMT compared with VEH with no
change evident in VEH-FMT rats. This suggests that changes in
brainstem 5-HTwere not pivotal to hypercapnic ventilatory depression.
Interestingly, an increase in 5-HT turnover was observed in the hippo-
campus and pre-frontal cortex following ABX treatment in rats [36],
germ free mice [87] and acutely stressed mice [37].
Dopamine significantly contributes to the central control of breath-
ing [88]. Transgenic mice lacking dopaminergic neurons or dopamine
transport proteins exhibit severe breathing disturbances such as
hypoventilation, apnoea and altered hypoxic ventilatory response
[89,90]. Similarly, blunted respiratory frequency during hypercapnic
breathing was observed in rat models of Parkinson's disease with con-
firmed degeneration of tyrosine hydroxylase expressing neurons in
the substantia nigra and a reduction in chemosensitive neurons
(Phox2b-expressing and fos-activated) in the retrotrapezoid nucleus
[91,92], a key brainstem site for CO2 chemosensitivity [93]. Themodula-
tory influence of dopamine on respiratory physiology is complex and
depends on target receptor sub-families [94]. There are 2 classes of do-
pamine receptors, D1-like (D1 and D5) and D2-like (D2, D3 and D4) re-
ceptors [95], with D1, D2 and D4 receptors having a significant
neuromodulatory role in respiration [88,96,97]. Dopaminergic neurons
within the brainstem reinforce CO2-dependent respiratory drive and in-
crease minute ventilation, predominantly through the D1 receptor
[97,98]. Thus, it appears that D1 receptor activation increases respiratory
neuron excitability, whereas D2 and D4 receptor stimulation depresses
respiratory rhythm [96,97,99]. Our data reveal an increase in brainstem
dopamine turnover in ABX rats and depressed ventilation during hyper-
capnia compared with VEH rats. Similar findings are reported in
Parkinson's disease models [91,92,100]. An increase in the dopamine
metabolite HVA was also evident in the cerebellum of ABX rats com-
pared with VEH rats in our study (Supplementary Table 10). Increased
concentrations of HVA were observed in the prefrontal cortex and
amygdala of ABX-treated rodents [36,37]. We observed depressed re-
spiratory frequency responses to hypercapnic stress in ABX and FMT
groups, which may have related to increased dopaminergic signalling
via D2 and D4 receptors [96,97,99].
Our findings demonstrate that disruption to the gut microbiota re-
sults in altered neurochemistry at the level of the brainstem and cere-
bellum, with striking effects on dopamine concentrations and
dopamine turnover. Correlation analysis revealed significant associa-
tions between brainstemneurochemistry and genera from 6 phyla, sug-
gesting a potential link. Of particular interest correlations were found
between L-DOPA, DA, HVA and HVA/DA and genera predominantly
of Firmicutes phylum; Ruminococcaceae UCG-005, Peptoclostridium,
Bacillus, Erysipelotrichaceae UCG-004, Ruminococcaceae UCG-011,
Lachnoclostridium 10, Clostridiales vadinBB60 group uncultured bacte-
rium and Ruminococcaceae UCG-009. Brainstem monoamines and
metabolites also correlate with Coriobacteriaceae uncultured
(Actinobacteria) Bacteroidetes VC2.1 Bac22 uncultured (Bacteroidetes),
Gastranaerophilales uncultured organism (Cyanobacteria), Helicobacter
(Proteobacteria) andMucispirillum (Deferribacteres).We acknowledge
that correlations were often weak and in any event do not provide evi-
dence of amechanistic link. Disrupted brainstem neurochemistry is also
evident in other models of microbiota perturbation. Germ free mice
have increased 5-HT in hippocampal regions and acutely stressed and
non-stressed ABX-treated animals have an increase in HVA in prefrontal
cortex and amygdala [36,37,87]. To assess if altered afferent vagal nerve
communication (gut-brain axis) contributed to the altered brainstem
neurochemistry and respiratory behaviour, future studies exploring
manipulation of the gut microbiota in vagotomised animals are re-
quired. However, vagal axotomy may itself evoke plasticity with the
brainstem neural circuits controlling cardiorespiratory control, which
may be a confounding factor in such studies.
4.6. Chronic antibiotic administration and faecal microbiota transfer
increase distal ileum permeability
Altered intestinal permeability has been described in variousmodels
of disrupted microbiota including a mouse model of autism [7], sponta-
neously hypertensive rat [13], and rat models of maternal separation
stress [15,101] and pre-natal stress [15]. The dysfunctional barrier of
the distal ileum in ABX and FMT rats in our study is consistent with
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reports of disrupted intestinal permeability in response to specific anti-
biotics, which also perturb the microbiota [102,103]. An impaired epi-
thelial barrier can induce low-grade inflammation and facilitate the
passage of bacterial constituents, such as lipopolysaccharide across the
epithelium into systemic tissues [104]. It is conceivable that the ‘leaky’
distal ileum could have, at least partially, contributed to modulation of
brainstem neurochemistry and depressed ventilatory responsiveness
to CO2. However, ABX rats may have limited maladies associated with
intestinal barrier breach due to reduced bacterial components and/or
the direct effects of antibiotics on other inflammatory mediators.
The shifts evident in Helicobacter and Mucispirillum genera are of
particular interest with respect to gastrointestinal health. Of critical im-
portance, the highest log-fold change occurred in Helicobacter, which
was significantly increased both in VEH-FMT and ABX-FMT rats com-
pared with VEH rats. Guo et al. 2009 found that Helicobacter pylori was
increased in the stomach of Balb/c mice in response to stress [105]. A
similar stress could have been evoked by the use of oral gavage,
resulting in increased abundance ofHelicobacter. The dominance of var-
ious species from Helicobacter genera in the gut microbiota coincides
with gastrointestinal disorders in humans and rodents, often triggering
intestinal inflammatory pathogenesis [106]. A mucin degrading bacte-
riumMucispirillumwas decreased in VEH-FMT and ABX-FMT rats com-
pared with VEH. Increased abundance of Mucispirillum coincides with
inflammatory response in germ-free mice [107], in a model of colitis
[108], and in age-related inflammation in rodents [109]. It is plausible
that Helicobacter proliferated at the expense ofMucispirillum. Intestinal
pathogenesis could have occurred as a result of insults to themicrobiota
associated with our interventions.
4.7. Limitations
Our FMT strategy was designed to replenish the microbiota of ABX
rats. To control for the FMT intervention, VEH rats also received FMT
and were studied in parallel. However, FMT per se causedmajor disrup-
tion to the microbiota composition and diversity compared with VEH
rats. As such, our study did not allow us to determine if restoration of
normal (control) gutmicrobiota was associatedwith restoration of nor-
mal (control) brainstem neurochemistry and ventilatory responsive-
ness to hypercapnia. Whereas this is a limitation of the study, it
nevertheless provided unexpected additional test groups (FMT groups),
wherein gutmicrobiota disruptionswere shown to be related to altered
brainstem neurochemistry and blunted ventilatory responsiveness to
CO2, in essence confirming the observationsmade in ABX rats compared
with VEH rats. Future studies could explore the capacity to transfer the
phenotypes described in the present study from ABX donor to naïve re-
cipient animals. Moreover, it would be interesting to explore FMT strat-
egies designed to recover brainstem neurochemistry and ventilatory
responsiveness to hypercapnia in ABX-treated rats.
DNA concentrations in caecal samples from ABX rats were critically
low, likely a result of the broad-spectrum antibiotic cocktail depleting
bacteria and thus detectable bacterial DNA. This prevented the analysis
of microbiota composition and diversity analysis as 16S rRNA sequenc-
ing was not possible in this group. Thus, correlation analysis was per-
formed with metadata and microbiota composition from three groups
(VEH, VEH-FMT and ABX-FMT).
Our study design was such that we were unable to perform correla-
tions between breathing parameters and microbiota in ABX-treated
rats, since ABX rats studied in the plethysmograph proceeded to FMT
intervention.
4.8. Summary and conclusions
Using two modes to manipulate the gut microbiota (ABX and FMT),
our study suggests that perturbation to the gut microbiota has conse-
quences for brainstem neurochemistry and respiratory control. Our
study reveals the capacity for chronic antibiotic administration and
faecal microbiota transfer to affect respiratory behaviour, blunting a
critical homeostatic reflex defence or integrated behavioural response
to acute hypercapnic stress, with resultant consequences for acid-base
status. Our results may have relevance to human respiratory disorders
of the lungs or neural control networks, such as chronic obstructive pul-
monary diseases and sleep disordered breathing, where there is evi-
dence of altered gut microbiota composition. Blunted chemoreflex
control of breathing,wherein arterial blood CO2 levels can rise due to in-
adequate ventilatory drive, is a risk for the development of significant
respiratory acidosis, with whole-body consequences. Our study adds
to emerging evidence providing a rationale for manipulation of the
gut microbiota as an adjunctive therapy in cardiorespiratory diseases.
Supplementary data to this article can be found online at https://doi.
org/10.1016/j.ebiom.2019.03.029.
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